In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

AFT Pharmaceuticals Limited Balance Sheet Statement - Assets

As of 31 Mar 2020, The total current assets of AFT Pharmaceuticals Limited (ASX:AFP) was around $55,336,000 which consisted of $6,119,000 of Cash, $22,734,000 of Inventory and $22,627,000 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in NZD

Cash
$6.12M
Current assets
$55.34M
Total assets
$87.05M

The latest balance sheet of AFT Pharmaceuticals Limited also showed $4,027,000 of Property Plant Equipment and no Good will. Also there were $15,462,000 of Intangible assets and $12,227,000 of Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $87,052,000.

AFT Pharmaceuticals Limited Balance Sheet Statement - Liabilities

AFP's latest annual results shows the balance sheet has $8,622,000 of Accounts Payable. Also there were $2,000,000 of Short/Long term debt, $41,200,000 of Long term debt, $7,393,000 of Other Current liabilities and $25,102,000 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$8.62M
Current liabilities
$25.1M
Total liabilities
$69.8M

As per the 31 Mar 2020's annual report of AFT Pharmaceuticals Limited, the total liabilities were $69,797,000.

AFP Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of AFT Pharmaceuticals Limited showed the total stock holder equity was $6,462,000 which consisted of $57,061,000 of Common stocks, $-49,275,000 of Retained earnings and $-1,324,000 of Other stock holder equity.

AFP Balance Sheet Statement History

Following table shows the history of balance sheet for AFT Pharmaceuticals Limited (AFP).

31 Mar 202031 Mar 201931 Mar 201831 Mar 2017
Cash6.12M6.92M6.77M15.9M
Net Receivables22.63M16.28M14.78M14.02M
Inventory22.73M25.16M24.41M22.2M
Total Current Assets55.34M51.26M48.31M54.15M
Property Plant Equipment4.03M357k330k386k
Good Will----
Intangible Assets15.46M2.91M2.65M2.55M
Other Assets12.23M6.03M3.17M610k
Deferred Long Term Asset Charges705k705k708k610k
Total Assets87.05M63.59M56.6M58.33M
Accounts Payable8.62M6.67M7.33M10.83M
Short/Long Term Debt2M41.75M--
Other Current Liabilities7.39M6.63M8.05M2.26M
Long Term Debt41.2M-30.65M23.43M
Other Liabilities----
Total Current Liabilities25.1M58.5M18.61M15.43M
Total Liabilities69.8M58.5M49.26M38.85M
Common Stock57.06M57.06M57.06M55.99M
Retained Earnings-49.27M-61.01M-57.64M-44.02M
Treasury Stock-1.32M-1.33M-1.68M-1.62M
Other Stockholder Equity-1.32M-1.33M-1.68M-1.62M
Total Stockholder Equity6.46M-5.27M-2.27M10.35M
Net Tangible Assets-9M-8.19M-4.92M7.8M

AFT Pharmaceuticals Limited (ASX:AFP) Balance Sheet Statement FAQ

1. How much Cash AFT Pharmaceuticals Limited has on their balance sheet?

As of 31 Mar 2020, AFT Pharmaceuticals Limited (ASX:AFP) has $6,119,000 of Cash.

2. What's the long term debt of AFT Pharmaceuticals Limited?

As per the latest Balance sheet of AFT Pharmaceuticals Limited (ASX:AFP), it has $41,200,000 of Long term debt.

3. How much share holder equity does AFT Pharmaceuticals Limited has?

The AFT Pharmaceuticals Limited (ASX:AFP)'s balance sheet shows that it has $6,462,000 of Total stock holder equity.